{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:54:55Z","timestamp":1761602095338,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jcf.2020.08.018","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T18:29:37Z","timestamp":1599848977000},"page":"330-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute hyperosmolar hyperglycaemic state in cystic fibrosis-related diabetes caused by glucocorticoid and itraconazole interaction"],"prefix":"10.1016","volume":"20","author":[{"given":"Isaac T","family":"Bernhardt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Currie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0541-6094","authenticated-orcid":false,"given":"Craig A.","family":"Jefferies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 27","key":"10.1016\/j.jcf.2020.08.018_bib0001","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/pedi.12701","article-title":"ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state","volume":"19","author":"Wolfsdorf","year":"2018","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"10.1016\/j.jcf.2020.08.018_bib0002","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/dc16-0020","article-title":"Does \u03b2-cell autoimmunity play a role in cystic fibrosis-related diabetes? Analysis based on the German\/Austrian diabetes patienten verlaufsdokumentation registry","volume":"39","author":"Konrad","year":"2016","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.jcf.2020.08.018_bib0003","doi-asserted-by":"crossref","DOI":"10.2337\/dc11-2327","article-title":"No relation between cystic fibrosis-related diabetes and type 1 diabetes auto-immunity","volume":"35","author":"Gottlieb","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.jcf.2020.08.018_bib0004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s002280050720","article-title":"The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone","volume":"56","author":"Varis","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jcf.2020.08.018_bib0005","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.jcf.2014.09.007","article-title":"An unusual cause of growth failure in cystic fibrosis: a salutary reminder of the interaction between glucocorticoids and cytochrome p450 inhibiting medication","volume":"14","author":"Albert","year":"2015","journal-title":"J Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2020.08.018_bib0006","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcf.2012.10.007","article-title":"Itraconazole and inhaled fluticasone causing hypothalamic\u2013pituitary\u2013adrenal axis suppression in adults with cystic fibrosis","volume":"12","author":"Gilchrist","year":"2013","journal-title":"J Cystic Fibrosis"},{"key":"10.1016\/j.jcf.2020.08.018_bib0007","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1345\/aph.1D222","article-title":"Cushing\u2019s syndrome due to interaction between inhaled Fluticasone and Itraconazole","volume":"38","author":"Bolland","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"9019","key":"10.1016\/j.jcf.2020.08.018_bib0008","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(96)03339-9","article-title":"Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate","volume":"348","author":"Todd","year":"1996","journal-title":"Lancet"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320308559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199320308559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:43:59Z","timestamp":1761601439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199320308559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1569199320308559"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2020.08.018","relation":{},"ISSN":["1569-1993"],"issn-type":[{"type":"print","value":"1569-1993"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute hyperosmolar hyperglycaemic state in cystic fibrosis-related diabetes caused by glucocorticoid and itraconazole interaction","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2020.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}